Back to search
FDAFDA · Food and drugs·Recall number Z-2172-2026

Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO

Published May 20, 2026 · Recall initiated: March 27, 2026

Summary

FDA records medical device Class II recall Z-2172-2026, published May 20, 2026 and initiated March 27, 2026. Recalling firm: Edwards Lifesciences, LLC; Status: Ongoing; Lot: All Lots/UDI:0690103D004EVD000V5. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Edwards Lifesciences, LLC
Distributor
Worldwide - US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Saudi Arabia, Germany, United Kingdom.
Lot
All Lots/UDI:0690103D004EVD000V5
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO recalled?

Yes. FDA published recall Z-2172-2026 on May 20, 2026. Reported hazard: Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail